Precision cut lung slices

Last updated

Precision cut lung slices or PCLS refer to thin sections of lung tissue that are prepared with high precision and are typically used for experimental purposes in the field of respiratory research. [1] These slices are utilized to study various aspects of lung physiology, pathology, and pharmacology, providing researchers with a valuable tool for investigating lung diseases and testing the effects of drugs on lung tissue. [2]

Contents

Precision cut lung slices are prepared using specialized equipment called Vibratomes, ensuring that the tissue remains viable and retains its structural and functional characteristics, making them ideal for a wide range of experimental applications. [3] [4]

Dr. Ricardo Pineda, University of Pittsburgh. Mouse precision-cut lung slice (PCLS; 300 mm) stained for collagen & fibronectin. Made with a vibratome. PCLS Image.png
Dr. Ricardo Pineda, University of Pittsburgh. Mouse precision-cut lung slice (PCLS; 300 μm) stained for collagen & fibronectin. Made with a vibratome.

History

The history of Precision-cut Lung Slices (PCLS) dates back to the 1920s when scientists first explored tissue slices for studying organ metabolism and toxicology. Initially, manual slicing of tissues, such as the liver, led to significant variability in thickness and limited viability. [5]

A critical advancement occurred in the 1940s when Stadie and Riggs introduced a microtome equipped with a thin razor blade, reducing thickness variability to about 5%. These improved slices became known as precision-cut tissue slices. [6]

Creating PCLS posed unique challenges due to the lung's intricate structure. In the 1980s, Placke and Fisher achieved a breakthrough by infusing heated liquid agarose into the airways of hamster and rat lungs, preventing airway and alveolar collapse during slicing. [6]

Basic preparation

Creating Precision-cut Lung Slices (PCLS) is a meticulous process that involves several essential steps. The use of vibratomes is crucial in ensuring the production of precise and high-quality lung slices for research purposes. [7]

Use of vibratomes

A. Preparation of lung tissue on a sample holder B. Setup to obtain slices. C. Generation of precision-cut lung slices using a vibratome. Compresstome v.png
A. Preparation of lung tissue on a sample holder B. Setup to obtain slices. C. Generation of precision-cut lung slices using a vibratome.

The basic steps involved in preparing PCLS using vibratomes include: [8]

Tissue Selection
Start by carefully selecting lung tissue from the desired species, such as rodents or humans, ensuring the tissue is of high quality and health.
Tissue Embedding
To facilitate slicing and maintain tissue structure, the lung tissue is typically embedded in a suitable medium, such as agarose or gelatin, into the specimen holder of the vibratome.
Slicing Process
The vibratome operates by oscillating a blade vertically or horizontally at high frequencies while the tissue is submerged in a cutting solution. This mechanical oscillation creates thin and precise slices of lung tissue. Researchers can adjust cutting parameters, such as slice thickness, to meet specific experimental requirements. Typically, PCLS have thicknesses ranging from 200-500 μm.
Post-processing
Depending on the research objectives, PCLS may undergo additional steps such as washing, culturing, or treatment with substances of interest, such as drugs or stimuli.

Maintenance of PCLS

Ensuring the viability of Precision-cut Lung Slices (PCLS) during ex vivo maintenance presents several challenges. Typically, PCLS are submerged in culture medium within multi-well plates, simulating tissue culture conditions at 37 °C, 5% CO2, and 95–100% air humidity. [9] The culture medium is refreshed daily and optimized with essential nutrients, enabling viable PCLS to be maintained for up to 14 days, a significant improvement compared to previous reports of only 3–5 days. [10] Additionally, the inclusion of antibiotics like penicillin and streptomycin helps prevent pathogen contamination from the outset of culture. [11]

While in culture, PCLS retain their viability, normal metabolic activity, tissue integrity, and responsiveness to stimuli such as lipopolysaccharide (LPS). [10] However, it's important to note that extended culture periods may lead to some changes in PCLS function. For instance, although human PCLS can contract in response to methacholine, the secretion of LPS-induced TNF-α, while maintained, may diminish over time. [12] Furthermore, long-term cultivation can result in the loss of certain cell populations, such as pneumocytes and lymphocytes, as well as the degradation of connective tissue fibers. These changes may contribute to decreased sensitivity of cultured PCLS to external stimuli. [12]

In practice, PCLS can maintain comparable viability and tissue homeostasis for 1 to 3 days, though extended periods can be achieved with optimized culture conditions. [13]

Experimental applications

Precision-cut lung slices find extensive use in a variety of experimental applications in the field of respiratory research. Some of the key areas where PCLS are employed include:

Asthma

In the pursuit of understanding and developing treatments for asthma, researchers have explored various models, including animal models like mice and rats, to mimic different aspects of the condition. While these animal models have contributed to our knowledge, they come with limitations, particularly in terms of translatability to humans. [14]

To address these limitations and enhance our understanding of asthma, researchers have turned to human Precision-cut Lung Slices (PCLS) obtained from both healthy and diseased individuals as a valuable ex vivo tool. [15] PCLS derived from healthy and asthmatic lungs exhibit altered responses to various stimuli, including bronchoconstriction and hyperresponsiveness, which closely resemble those observed in patients and various animal models. [15]

Moreover, PCLS from individuals with asthma have been shown to display significantly increased airway inflammation and hyperresponsiveness when stimulated by factors such as rhinovirus. [16] These PCLS also exhibit elevated gene expression related to asthma pathogenesis, including genes like Il25, Tslp, and Il13. [17] These findings align with observations in asthmatic patients, indicating that PCLS models provide a promising platform for asthma research. [15]

COPD (Chronic Obstructive Pulmonary Disease)

While no in vivo models fully encompass all aspects of clinical COPD pathology, certain animal models, such as those involving cigarette smoke exposure, elastase-induced emphysema, and LPS challenge, have yielded valuable insights. For instance, exposing guinea pigs or mice to cigarette smoke can reproduce key features of human COPD, including emphysema, small airway remodeling, and pulmonary hypertension. However, this model typically manifests mild emphysema and requires months to develop. [18] In contrast, delivering elastase to the lungs of mice rapidly induces an emphysematous phenotype, allowing for controlled disease severity by adjusting elastase dose, administration route, and duration. [19] It's worth noting that the physiological relevance of elastase and LPS models is debatable due to differences in underlying mechanisms. [20]

The use of Precision-cut Lung Slices (PCLS) from in vivo models has proven particularly valuable in modeling COPD. For instance, PCLS obtained from smoke-exposed mice have shown elevated expression of chemokines when stimulated with viral mimics or influenza A virus. [21] Murine PCLS have also demonstrated that Influenza A infection and cigarette smoke can impair bronchodilator responsiveness to β2-adrenoceptor agonists. Future studies employing PCLS from COPD patients hold the potential to enable both functional and phenotypic immune cell characterization, facilitating a more comprehensive understanding of molecular mechanisms underlying disease heterogeneity.

Idiopathic Pulmonary Fibrosis (IPF)

Precision-cut Lung Slices (PCLS) have proven effective in studying the early stages of lung fibrosis in IPF. When exposed to TGF-β1 and cadmium chloride, both human and rat PCLS have displayed relevant pathohistological changes commonly observed in the early phases of lung fibrosis. These changes include the upregulation of critical pro-fibrotic genes, increased thickness of alveolar septa, and abnormal activation of pulmonary cells. [22]

Recent advancements in research have led to the establishment of an ex vivo human PCLS model specifically focused on early-stage fibrosis. This model involves exposing PCLS to a combination of pro-fibrotic growth factors and signaling molecules, including TGF-β1, TNF-α, platelet-derived growth factor-AB, and lysophosphatidic acid. [23] This approach offers a pathway to investigate the underlying mechanisms of early IPF and assess novel therapies. [24]

Researchers are actively evaluating novel treatments for IPF using PCLS. For example, caffeine, which inhibits TGF-β-induced increases in pro-fibrotic gene expression, has shown promise by significantly reducing fibrosis in PCLS from bleomycin-treated mice. Additionally, targeting PI3K signaling has emerged as a promising anti-fibrotic treatment strategy, as demonstrated using PCLS derived from IPF patients. [24]

The use of PCLS in IPF research holds great potential for understanding the disease's early stages, testing innovative therapies, and uncovering novel treatment strategies.

Infection and Inflammation

Precision-cut Lung Slices (PCLS) have been instrumental in studying the body's innate responses to viral and, to a lesser extent, bacterial challenges. This system has shed light on which cells become infected within the intact lung, offering insights distinct from in vitro air-liquid interface cultures. [25]

Studies by Goris et al. have revealed variations in the infectability of different cell types within the lung. For instance, bovine parainfluenza virus infection was observed primarily in cells beneath the lung epithelium within the PCLS system. [26] [27] Importantly, this suggests that the epithelium, when in its natural physiological structure, resists infection. Similar findings were reported by Kirchhoff et al. [28] These studies emphasize the significance of studying cells within their physiological environment, considering cell associations and structural architecture. Such interactions not only affect infectability but also shape the system's response to infection.

The PCLS system serves as a valuable tool for understanding inflammatory responses. It has been employed to investigate the innate response to bacterial wall components like LPS and to conduct complex mixed infection studies involving multiple viruses or viral and bacterial co-infections. This approach enables precise analysis of immune responses to each stimulus. In simpler models, PCLS have been used to assess the impact of LPS on the innate immune response, testing the effects of various immunomodulators on innate signaling. [29] [23]

Furthermore, the ability to obtain slices from diseased lungs, such as those affected by conditions like COPD and asthma, provides a robust model for studying how respiratory diseases influence infectivity and host responses. This is particularly relevant for diseases like COPD and asthma, which have links to pathogen-induced exacerbations.

PCLS research in infection and inflammation enhances our understanding of immune responses, paving the way for insights into disease mechanisms and potential therapeutic strategies.

Drug Testing

Precision-cut Lung Slices (PCLS) play a crucial role in evaluating novel therapeutic targets for asthma, especially as tolerance to conventional treatments like glucocorticoids and β2-receptor agonists becomes more common. Researchers have increasingly focused on targets relevant to asthma pathogenesis, and PCLS have become a valuable tool for evaluating these targets as potential therapeutics. [30]

For instance, studies have shown that inhibiting histone deacetylase with trichostatin A can alleviate airway constriction in human PCLS and simultaneously reduce airway hyperresponsiveness in antigen-challenged mice. [31] Additionally, activating soluble guanylate cyclase in airway smooth muscle using riociguat and cinaciguat analogs has been found to induce bronchodilation in normal human PCLS and reverse airway hyperresponsiveness in allergic asthmatic mice, restoring normal lung function. [30] [32]

The use of PCLS in drug development is expanding further, with specific agonists or inhibitors targeting bitter-taste receptors, peroxisome proliferator-activated receptor (PPAR) γ, phosphoinositide-3 kinase (PI3K), BK channels, and spleen tyrosine kinase (Syk) all undergoing investigation within this context. [30] [33]

PCLS research contributes significantly to the development of innovative therapeutic strategies for asthma, addressing the evolving challenges of treatment resistance. [30]

Advantages of PCLS

Precision-cut Lung Slices (PCLS) offer several distinct advantages that make them invaluable tools in respiratory research. They excel in preserving the intricate lung architecture, maintaining essential tissue structures like small airways, respiratory parenchyma, structural and immune cell populations, and connective tissue. [34] The cellular composition within PCLS closely mirrors that of intact lungs, retaining the organization of structural and immune cells. [35] [36] However, it's important to note that specific cell types' distribution may vary among slices due to regional variability within the lung, especially in the presence of non-uniform disease-related changes. [37]

In certain contexts, PCLS can be considered as "mini" lungs. [38] While lacking a recruitable immune system, PCLS provide a unique opportunity to correlate cell-specific functions with organ physiology. They exhibit complex responses to challenges and stimuli, such as airway contraction and immune responses, shedding light on disease mechanisms and treatment evaluations. [39]

PCLS have found applications in a wide range of respiratory research areas, including asthma, COPD, idiopathic pulmonary fibrosis, allergies, infections, and toxicology studies. Researchers have harnessed the advantages of PCLS to model and study these prominent respiratory diseases, facilitating insights and translational relevance to human disease. [37]

Limitations of PCLS

Precision-cut Lung Slices (PCLS) provide valuable insights into lung physiology and pathology, but they do have limitations. Firstly, PCLS represent a static "snapshot" of lung tissue at the time of excision, lacking access to the dynamic, recruitable immune system present in living organisms. This limitation hinders the full understanding of immune responses within the lung. [40]

Furthermore, lung tissue is inherently heterogeneous, with variations in epithelial integrity, immune cell populations, and responses to stimulation across different lung regions. When studying diseases, such as respiratory conditions, this heterogeneity can complicate data interpretation, requiring careful statistical analysis to account for variability between slices. [41] [42]

PCLS have a limited ability to fully replicate the intricate and dynamic immune responses observed in living organisms. They cannot recruit non-resident immune cells, and their viability is restricted to approximately two weeks. [43] While they can capture initial signals induced by pathogens, they cannot fully mimic the complex immune responses seen in a living lung. [44]

Another limitation is that PCLS are typically used as static systems and do not replicate the natural breathing motion of the lung. [45] This is particularly relevant when studying diseases like ventilator-induced lung injury, where mechanical stress from ventilation plays a crucial role. Attempts to stretch or deform PCLS have been made to simulate mechanical dynamics, but accurately replicating these processes remains a challenge. [46] [47] [48]

Administering treatments in PCLS can be challenging because the entire slice is bathed in the compound or stimulant of interest. This poses difficulties in translating findings to inhaled or systemic applications in vivo, making dosing and translation [49]

Administering treatments in PCLS can be challenging because the entire slice is bathed in the compound or stimulant of interest. This poses difficulties in translating findings to inhaled or systemic applications in vivo, making dosing and translation complex. [48] [50]

See also

Related Research Articles

<span class="mw-page-title-main">Lung</span> Primary organ of the respiratory system

The lungs are the main organs of the respiratory system in many terrestrial animals, including all tetrapod vertebrates and a small number of amphibious fish, pulmonate gastropods, and some arachnids. Their function is to conduct gas exchange by extracting oxygen from the air into the bloodstream via diffusion directly across the humidified airway epithelia, and to release carbon dioxide from the bloodstream out into the atmosphere, a process also known as respiration. This article is primarily concerned with the lungs of tetrapods, which are paired and located on either side of the heart, occupying most of the volume of the thoracic cavity, and are homologous to the swim bladders in ray-finned fish.

<span class="mw-page-title-main">Eosinophil</span> Variety of white blood cells

Eosinophils, sometimes called eosinophiles or, less commonly, acidophils, are a variety of white blood cells and one of the immune system components responsible for combating multicellular parasites and certain infections in vertebrates. Along with mast cells and basophils, they also control mechanisms associated with allergy and asthma. They are granulocytes that develop during hematopoiesis in the bone marrow before migrating into blood, after which they are terminally differentiated and do not multiply.

<span class="mw-page-title-main">Respiratory syncytial virus</span> Species of virus

Respiratory syncytial virus (RSV), also called human respiratory syncytial virus (hRSV) and human orthopneumovirus, is a contagious virus that causes infections of the respiratory tract. It is a negative-sense, single-stranded RNA virus. Its name is derived from the large cells known as syncytia that form when infected cells fuse.

<span class="mw-page-title-main">Interleukin 4</span> Mammalian protein found in Mus musculus

The interleukin 4 is a cytokine that induces differentiation of naive helper T cells (Th0 cells) to Th2 cells. Upon activation by IL-4, Th2 cells subsequently produce additional IL-4 in a positive feedback loop. IL-4 is produced primarily by mast cells, Th2 cells, eosinophils and basophils. It is closely related and has functions similar to IL-13.

<span class="mw-page-title-main">Interleukin 13</span> Protein and coding gene in humans

Interleukin 13 (IL-13) is a protein that in humans is encoded by the IL13 gene. IL-13 was first cloned in 1993 and is located on chromosome 5q31.1 with a length of 1.4kb. It has a mass of 13 kDa and folds into 4 alpha helical bundles. The secondary structural features of IL-13 are similar to that of Interleukin 4 (IL-4); however it only has 25% sequence identity to IL-4 and is capable of IL-4 independent signaling. IL-13 is a cytokine secreted by T helper type 2 (Th2) cells, CD4 cells, natural killer T cell, mast cells, basophils, eosinophils and nuocytes. Interleukin-13 is a central regulator in IgE synthesis, goblet cell hyperplasia, mucus hypersecretion, airway hyperresponsiveness, fibrosis and chitinase up-regulation. It is a mediator of allergic inflammation and different diseases including asthma, and atopic dermatitis.

<span class="mw-page-title-main">Allergic bronchopulmonary aspergillosis</span> Medical condition

Allergic bronchopulmonary aspergillosis (ABPA) is a condition characterised by an exaggerated response of the immune system to the fungus Aspergillus. It occurs most often in people with asthma or cystic fibrosis. Aspergillus spores are ubiquitous in soil and are commonly found in the sputum of healthy individuals. A. fumigatus is responsible for a spectrum of lung diseases known as aspergilloses.

<span class="mw-page-title-main">Alveolar macrophage</span> Macrophage found in the lungs

An alveolar macrophage, pulmonary macrophage, is a type of macrophage, a professional phagocyte, found in the airways and at the level of the alveoli in the lungs, but separated from their walls.

Arachidonate 5-lipoxygenase, also known as ALOX5, 5-lipoxygenase, 5-LOX, or 5-LO, is a non-heme iron-containing enzyme that in humans is encoded by the ALOX5 gene. Arachidonate 5-lipoxygenase is a member of the lipoxygenase family of enzymes. It transforms essential fatty acids (EFA) substrates into leukotrienes as well as a wide range of other biologically active products. ALOX5 is a current target for pharmaceutical intervention in a number of diseases.

<span class="mw-page-title-main">Surfactant protein A1</span> Protein-coding gene in the species Homo sapiens

Surfactant protein A1(SP-A1), also known as Pulmonary surfactant-associated protein A1(PSP-A) is a protein that in humans is encoded by the SFTPA1 gene.

<span class="mw-page-title-main">Cysteinyl leukotriene receptor 1</span> Protein-coding gene in humans

Cysteinyl leukotriene receptor 1, also termed CYSLTR1, is a receptor for cysteinyl leukotrienes (LT). CYSLTR1, by binding these cysteinyl LTs contributes to mediating various allergic and hypersensitivity reactions in humans as well as models of the reactions in other animals.

<span class="mw-page-title-main">Prostacyclin receptor</span> Mammalian protein found in Homo sapiens

The prostacyclin receptor, also termed the prostaglandin I2 receptor or just IP, is a receptor belonging to the prostaglandin (PG) group of receptors. IP binds to and mediates the biological actions of prostacyclin (also termed prostaglandin I2, PGI2, or when used as a drug, epoprostenol). IP is encoded in humans by the PTGIR gene. While possessing many functions as defined in animal model studies, the major clinical relevancy of IP is as a powerful vasodilator: stimulators of IP are used to treat severe and even life-threatening diseases involving pathological vasoconstriction.

<span class="mw-page-title-main">Interleukin-17A</span> Protein-coding gene in the species Homo sapiens

Interleukin-17A is a protein that in humans is encoded by the IL17A gene. In rodents, IL-17A used to be referred to as CTLA8, after the similarity with a viral gene.

<span class="mw-page-title-main">Surfactant protein A2</span> Protein-coding gene in the species Homo sapiens

Surfactant protein A2(SP-A2), also known as Pulmonary surfactant-associated protein A2(PSP-A2) is a protein that in humans is encoded by the SFTPA2 gene.

<span class="mw-page-title-main">Pathophysiology of asthma</span> Medical condition

Asthma is a common pulmonary condition defined by chronic inflammation of respiratory tubes, tightening of respiratory smooth muscle, and episodes of bronchoconstriction. The Centers for Disease Control and Prevention estimate that 1 in 11 children and 1 in 12 adults have asthma in the United States of America. According to the World Health Organization, asthma affects 235 million people worldwide. There are two major categories of asthma: allergic and non-allergic. The focus of this article will be allergic asthma. In both cases, bronchoconstriction is prominent.

The lung microbiota is the pulmonary microbial community consisting of a complex variety of microorganisms found in the lower respiratory tract particularly on the mucous layer and the epithelial surfaces. These microorganisms include bacteria, fungi, viruses and bacteriophages. The bacterial part of the microbiota has been more closely studied. It consists of a core of nine genera: Prevotella, Sphingomonas, Pseudomonas, Acinetobacter, Fusobacterium, Megasphaera, Veillonella, Staphylococcus, and Streptococcus. They are aerobes as well as anaerobes and aerotolerant bacteria. The microbial communities are highly variable in particular individuals and compose of about 140 distinct families. The bronchial tree for instance contains a mean of 2000 bacterial genomes per cm2 surface. The harmful or potentially harmful bacteria are also detected routinely in respiratory specimens. The most significant are Moraxella catarrhalis, Haemophilus influenzae, and Streptococcus pneumoniae. They are known to cause respiratory disorders under particular conditions namely if the human immune system is impaired. The mechanism by which they persist in the lower airways in healthy individuals is unknown.

Chronic Mycoplasma pneumonia and Chlamydia pneumonia infections are associated with the onset and exacerbation of asthma. These microbial infections result in chronic lower airway inflammation, impaired mucociliary clearance, an increase in mucous production and eventually asthma. Furthermore, children who experience severe viral respiratory infections early in life have a high possibility of having asthma later in their childhood. These viral respiratory infections are mostly caused by respiratory syncytial virus (RSV) and human rhinovirus (HRV). Although RSV infections increase the risk of asthma in early childhood, the association between asthma and RSV decreases with increasing age. HRV on the other hand is an important cause of bronchiolitis and is strongly associated with asthma development. In children and adults with established asthma, viral upper respiratory tract infections (URIs), especially HRVs infections, can produce acute exacerbations of asthma. Thus, Chlamydia pneumoniae, Mycoplasma pneumoniae and human rhinoviruses are microbes that play a major role in non-atopic asthma.

Innate lymphoid cells (ILCs) are the most recently discovered family of innate immune cells, derived from common lymphoid progenitors (CLPs). In response to pathogenic tissue damage, ILCs contribute to immunity via the secretion of signalling molecules, and the regulation of both innate and adaptive immune cells. ILCs are primarily tissue resident cells, found in both lymphoid, and non- lymphoid tissues, and rarely in the blood. They are particularly abundant at mucosal surfaces, playing a key role in mucosal immunity and homeostasis. Characteristics allowing their differentiation from other immune cells include the regular lymphoid morphology, absence of rearranged antigen receptors found on T cells and B cells, and phenotypic markers usually present on myeloid or dendritic cells.

<span class="mw-page-title-main">ILC2</span>

ILC2 cells, or type 2 innate lymphoid cells are a type of innate lymphoid cell. Not to be confused with the ILC. They are derived from common lymphoid progenitor and belong to the lymphoid lineage. These cells lack antigen specific B or T cell receptor because of the lack of recombination activating gene. ILC2s produce type 2 cytokines and are involved in responses to helminths, allergens, some viruses, such as influenza virus and cancer.

Donna Elizabeth Davies is a British biochemist and professor of respiratory cell and molecular biology at the University of Southampton. In 2003, Davies was the co-founder of Synairgen, an interferon-beta drug designed to treat patients with asthma and chronic obstructive pulmonary disease.

<span class="mw-page-title-main">Smoker's macrophages</span> Alveolar macrophages whose characteristics have been affected by smoking

Smoker's macrophages are alveolar macrophages whose characteristics, including appearance, cellularity, phenotypes, immune response, and other functions, have been affected upon the exposure to cigarettes. These altered immune cells are derived from several signaling pathways and are able to induce numerous respiratory diseases. They are involved in asthma, chronic obstructive pulmonary diseases (COPD), pulmonary fibrosis, and lung cancer. Smoker’s macrophages are observed in both firsthand and secondhand smokers, so anyone exposed to cigarette contents, or cigarette smoke extract (CSE), would be susceptible to these macrophages, thus in turns leading to future complications.

References

  1. ↑ Morin, Jean-Paul; Baste, Jean-Marc; Gay, Arnaud; Crochemore, Clément; Corbière, Cécile; Monteil, Christelle (2013). "Precision cut lung slices as an efficient tool for in vitro lung physio-pharmacotoxicology studies". Xenobiotica. 43 (1): 63–72. doi:10.3109/00498254.2012.727043. PMID   23030793. S2CID   207427454.
  2. ↑ Liu, Yan; Wu, Ping; Wang, Yin; Liu, Yansong; Yang, Hongfang; Zhou, Guohua; Wu, Xiaoqi; Wen, Qingping (2022). "Application of Precision-Cut Lung Slices as an in Vitro Model for Research of Inflammatory Respiratory Diseases". Bioengineering. 9 (12): 767. doi: 10.3390/bioengineering9120767 . PMC   9774555 . PMID   36550973.
  3. ↑ Sewald, K.; Braun, A. (2013). "Assessment of immunotoxicity using precision-cut tissue slices". Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 43 (1): 84–97. doi:10.3109/00498254.2012.731543. PMC   3518294 . PMID   23199366.
  4. ↑ Abdelaal, H. M.; Kim, H. O.; Wagstaff R; Sawahata, R.; Southern, P. J.; Skinner, P. J. (2015). "Comparison of Vibratome and Compresstome sectioning of fresh primate lymphoid and genital tissues for in situ MHC-tetramer and immunofluorescence staining". Biological Procedures Online. 17 (1): 2. doi: 10.1186/s12575-014-0012-4 . PMC   4318225 . PMID   25657614.
  5. ↑ Lam, Maggie; Lamanna, Emma; Organ, Louise; Donovan, Chantal; Bourke, Jane E. (2023). "Perspectives on precision cut lung slices—powerful tools for investigation of mechanisms and therapeutic targets in lung diseases". Frontiers in Pharmacology. 14. doi: 10.3389/fphar.2023.1162889 . PMC   10228656 . PMID   37261291.
  6. 1 2 Alsafadi, Hani N.; Uhl, Franziska E.; Pineda, Ricardo H.; Bailey, Kolene E.; Rojas, Mauricio; Wagner, Darcy E.; Königshoff, Melanie (2020). "Applications and Approaches for Three-Dimensional Precision-Cut Lung Slices. Disease Modeling and Drug Discovery". American Journal of Respiratory Cell and Molecular Biology. 62 (6): 681–691. doi:10.1165/rcmb.2019-0276TR. PMC   7401444 . PMID   31991090.
  7. ↑ Akram, Khondoker M.; Yates, Laura L.; Mongey, Róisín; Rothery, Stephen; Gaboriau, David C. A.; Sanderson, Jeremy; Hind, Matthew; Griffiths, Mark; Dean, Charlotte H. (2019). "Live imaging of alveologenesis in precision-cut lung slices reveals dynamic epithelial cell behaviour". Nature Communications. 10 (1): 1178. Bibcode:2019NatCo..10.1178A. doi:10.1038/s41467-019-09067-3. PMC   6414680 . PMID   30862802.
  8. ↑ Michalaki, Christina; Dean, Charlotte; Johansson, Cecilia (2022). "The Use of Precision-Cut Lung Slices for Studying Innate Immunity to Viral Infections". Current Protocols. 2 (8): e505. doi:10.1002/cpz1.505. hdl:10044/1/99043. PMC   9545600 . PMID   35938685.
  9. ↑ Dimou, Paraskevi; Trivedi, Sumita; Liousia, Maria; d'Souza, Reena R.; Klampatsa, Astero (2022). "Precision-Cut Tumor Slices (PCTS) as an Ex Vivo Model in Immunotherapy Research". Antibodies. 11 (2): 26. doi: 10.3390/antib11020026 . PMC   9036232 . PMID   35466279.
  10. 1 2 Temann, A.; Golovina, T.; Neuhaus, V.; Thompson, C.; Chichester, J. A.; Braun, A.; Yusibov, V. (2017). "Evaluation of inflammatory and immune responses in long-term cultured human precision-cut lung slices". Human Vaccines & Immunotherapeutics. 13 (2): 351–358. doi:10.1080/21645515.2017.1264794. PMC   5328235 . PMID   27929748.
  11. ↑ Preuß, Eike B.; Schubert, Stephanie; Werlein, Christopher; Stark, Helge; Braubach, Peter; Höfer, Anne; Plucinski, Edith K.J.; Shah, Harshit R.; Geffers, Robert; Sewald, Katherina; Braun, Armin; Jonigk, Danny D.; Kühnel, Mark P. (2022). "The Challenge of Long-Term Cultivation of Human Precision-Cut Lung Slices". The American Journal of Pathology. 192 (2): 239–253. doi:10.1016/j.ajpath.2021.10.020. PMC   8891143 . PMID   34767811.
  12. 1 2 Neuhaus, V.; Schaudien, D.; Golovina, T.; Temann, U. A.; Thompson, C.; Lippmann, T.; Bersch, C.; Pfennig, O.; Jonigk, D.; Braubach, P.; Fieguth, H. G.; Warnecke, G.; Yusibov, V.; Sewald, K.; Braun, A. (2017). "Assessment of long-term cultivated human precision-cut lung slices as an ex vivo system for evaluation of chronic cytotoxicity and functionality". Journal of Occupational Medicine and Toxicology. 12: 13. doi: 10.1186/s12995-017-0158-5 . PMC   5446749 . PMID   28559920.
  13. ↑ Sanderson, M. J. (2011). "Exploring lung physiology in health and disease with lung slices". Pulmonary Pharmacology & Therapeutics. 24 (5): 452–465. doi:10.1016/j.pupt.2011.05.001. PMC   3168687 . PMID   21600999.
  14. ↑ Mullane, K.; Williams, M. (2014). "Animal models of asthma: Reprise or reboot?". Biochemical Pharmacology. 87 (1): 131–139. doi:10.1016/j.bcp.2013.06.026. PMID   23831953.
  15. 1 2 3 Wohlsen, A.; Martin, C.; Vollmer, E.; Branscheid, D.; Magnussen, H.; Becker, W. M.; Lepp, U.; Uhlig, S. (2003). "The early allergic response in small airways of human precision-cut lung slices". The European Respiratory Journal. 21 (6): 1024–1032. doi: 10.1183/09031936.03.00027502 . PMID   12797499. S2CID   19972045.
  16. ↑ Kennedy, J. L.; Koziol-White, C. J.; Jeffus, S.; Rettiganti, M. R.; Fisher, P.; Kurten, M.; Eze, A.; House, S.; Sikes, J. D.; Askew, E.; Putt, C.; Panettieri, R. A.; Jones, S. M.; Kurten, R. C. (2018). "Effects of rhinovirus 39 infection on airway hyperresponsiveness to carbachol in human airways precision cut lung slices". The Journal of Allergy and Clinical Immunology. 141 (5): 1887–1890.e1. doi:10.1016/j.jaci.2017.11.041. PMC   5938135 . PMID   29317243.
  17. ↑ Ying, S.; O'Connor, B.; Ratoff, J.; Meng, Q.; Fang, C.; Cousins, D.; Zhang, G.; Gu, S.; Gao, Z.; Shamji, B.; Edwards, M. J.; Lee, T. H.; Corrigan, C. J. (2008). "Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease". Journal of Immunology. 181 (4): 2790–2798. doi: 10.4049/jimmunol.181.4.2790 . PMID   18684970. S2CID   86013485.
  18. ↑ Wright, J. L.; Cosio, M.; Churg, A. (2008). "Animal models of chronic obstructive pulmonary disease". American Journal of Physiology. Lung Cellular and Molecular Physiology. 295 (1): L1-15. doi:10.1152/ajplung.90200.2008. PMC   2494776 . PMID   18456796.
  19. ↑ Antunes, M. A.; Rocco, P. R. (2011). "Elastase-induced pulmonary emphysema: Insights from experimental models". Anais da Academia Brasileira de Ciências. 83 (4): 1385–1396. doi: 10.1590/s0001-37652011005000039 . PMID   22159348.
  20. ↑ Liu, G.; Särén, L.; Douglasson, H.; Zhou, X. H.; Åberg, P. M.; Ollerstam, A.; Betts, C. J.; Balogh Sivars, K. (2021). "Precision cut lung slices: An ex vivo model for assessing the impact of immunomodulatory therapeutics on lung immune responses". Archives of Toxicology. 95 (8): 2871–2877. doi:10.1007/s00204-021-03096-y. PMID   34191076. S2CID   235687459.
  21. ↑ Agraval, H.; Crue, T.; Schaunaman, N.; Numata, M.; Day, B. J.; Chu, H. W. (2023). "Electronic Cigarette Exposure Increases the Severity of Influenza a Virus Infection via TRAIL Dysregulation in Human Precision-Cut Lung Slices". International Journal of Molecular Sciences. 24 (5): 4295. doi: 10.3390/ijms24054295 . PMC   10002047 . PMID   36901724.
  22. ↑ Westra, I. M.; Pham, B. T.; Groothuis, G. M.; Olinga, P. (2013). "Evaluation of fibrosis in precision-cut tissue slices". Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 43 (1): 98–112. doi:10.3109/00498254.2012.723151. PMID   23002908. S2CID   11829880.
  23. 1 2 Alsafadi, H. N.; Staab-Weijnitz, C. A.; Lehmann, M.; Lindner, M.; Peschel, B.; Königshoff, M.; Wagner, D. E. (2017). "An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices". American Journal of Physiology. Lung Cellular and Molecular Physiology. 312 (6): L896–L902. doi: 10.1152/ajplung.00084.2017 . PMID   28314802. S2CID   2255748.
  24. 1 2 Cedilak, M.; Banjanac, M.; Belamarić, D.; Paravić Radičević, A.; Faraho, I.; Ilić, K.; Čužić, S.; Glojnarić, I.; Eraković Haber, V.; Bosnar, M. (2019). "Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis". Pulmonary Pharmacology & Therapeutics. 55: 75–83. doi:10.1016/j.pupt.2019.02.005. PMID   30776489. S2CID   73462721.
  25. ↑ Liu, G.; Betts, C.; Cunoosamy, D. M.; Åberg, P. M.; Hornberg, J. J.; Sivars, K. B.; Cohen, T. S. (2019). "Use of precision cut lung slices as a translational model for the study of lung biology". Respiratory Research. 20 (1): 162. doi: 10.1186/s12931-019-1131-x . PMC   6642541 . PMID   31324219.
  26. ↑ Goris, K.; Uhlenbruck, S.; Schwegmann-Wessels, C.; Köhl, W.; Niedorf, F.; Stern, M.; Hewicker-Trautwein, M.; Bals, R.; Taylor, G.; Braun, A.; Bicker, G.; Kietzmann, M.; Herrler, G. (2009). "Differential sensitivity of differentiated epithelial cells to respiratory viruses reveals different viral strategies of host infection". Journal of Virology. 83 (4): 1962–1968. doi:10.1128/JVI.01271-08. PMC   2643795 . PMID   19052091.
  27. ↑ Kirchhoff, J.; Uhlenbruck, S.; Goris, K.; Keil, G. M.; Herrler, G. (2014). "Three viruses of the bovine respiratory disease complex apply different strategies to initiate infection". Veterinary Research. 45 (1): 20. doi: 10.1186/1297-9716-45-20 . PMC   3942114 . PMID   24548739.
  28. ↑ Kirchhoff, J.; Uhlenbruck, S.; Keil, G. M.; Schwegmann-Wessels, C.; Ganter, M.; Herrler, G. (2014). "Infection of differentiated airway epithelial cells from caprine lungs by viruses of the bovine respiratory disease complex". Veterinary Microbiology. 170 (1–2): 58–64. doi:10.1016/j.vetmic.2014.01.038. PMID   24612951.
  29. ↑ Seehase, S.; Lauenstein, H. D.; Schlumbohm, C.; Switalla, S.; Neuhaus, V.; Förster, C.; Fieguth, H. G.; Pfennig, O.; Fuchs, E.; Kaup, F. J.; Bleyer, M.; Hohlfeld, J. M.; Braun, A.; Sewald, K.; Knauf, S. (2012). "LPS-induced lung inflammation in marmoset monkeys - an acute model for anti-inflammatory drug testing". PLOS ONE. 7 (8): e43709. Bibcode:2012PLoSO...743709S. doi: 10.1371/journal.pone.0043709 . PMC   3429492 . PMID   22952743.
  30. 1 2 3 4 https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00392-4/fulltext
  31. ↑ Banerjee, A.; Trivedi, C. M.; Damera, G.; Jiang, M.; Jester, W.; Hoshi, T.; Epstein, J. A.; Panettieri Jr, R. A. (2012). "Trichostatin a abrogates airway constriction, but not inflammation, in murine and human asthma models". American Journal of Respiratory Cell and Molecular Biology. 46 (2): 132–138. doi:10.1165/rcmb.2010-0276OC. PMC   3297166 . PMID   22298527.
  32. ↑ Ghosh, A.; Koziol-White, C. J.; Asosingh, K.; Cheng, G.; Ruple, L.; Groneberg, D.; Friebe, A.; Comhair, S. A.; Stasch, J. P.; Panettieri Jr, R. A.; Aronica, M. A.; Erzurum, S. C.; Stuehr, D. J. (2016). "Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma". Proceedings of the National Academy of Sciences of the United States of America. 113 (17): E2355-62. Bibcode:2016PNAS..113E2355G. doi: 10.1073/pnas.1524398113 . PMC   4855555 . PMID   27071111.
  33. ↑ Bai, Y.; Krishnamoorthy, N.; Patel, K. R.; Rosas, I.; Sanderson, M. J.; Ai, X. (2016). "Cryopreserved Human Precision-Cut Lung Slices as a Bioassay for Live Tissue Banking. A Viability Study of Bronchodilation with Bitter-Taste Receptor Agonists". American Journal of Respiratory Cell and Molecular Biology. 54 (5): 656–663. doi:10.1165/rcmb.2015-0290MA. PMC   4942196 . PMID   26550921.
  34. ↑ Alsafadi, H. N.; Uhl, F. E.; Pineda, R. H.; Bailey, K. E.; Rojas, M.; Wagner, D. E.; Königshoff, M. (2020). "Applications and Approaches for Three-Dimensional Precision-Cut Lung Slices. Disease Modeling and Drug Discovery". American Journal of Respiratory Cell and Molecular Biology. 62 (6): 681–691. doi:10.1165/rcmb.2019-0276TR. PMC   7401444 . PMID   31991090.
  35. ↑ Lyons-Cohen, M. R.; Thomas, S. Y.; Cook, D. N.; Nakano, H. (2017). "Precision-cut Mouse Lung Slices to Visualize Live Pulmonary Dendritic Cells". Journal of Visualized Experiments (122). doi:10.3791/55465. PMC   5512285 . PMID   28448013.
  36. ↑ Kretschmer, S.; Dethlefsen, I.; Hagner-Benes, S.; Marsh, L. M.; Garn, H.; König, P. (2013). "Visualization of intrapulmonary lymph vessels in healthy and inflamed murine lung using CD90/Thy-1 as a marker". PLOS ONE. 8 (2): e55201. Bibcode:2013PLoSO...855201K. doi: 10.1371/journal.pone.0055201 . PMC   3568125 . PMID   23408960.
  37. 1 2 Viana, F.; O'Kane, C. M.; Schroeder, G. N. (2021). "Precision-cut lung slices: A powerful ex vivo model to investigate respiratory infectious diseases". Molecular Microbiology. 117 (3): 578–588. doi:10.1111/mmi.14817. PMC   9298270 . PMID   34570407.
  38. ↑ "Precision-Cut Lung Slices (PCLS)".
  39. ↑ Temann, A.; Golovina, T.; Neuhaus, V.; Thompson, C.; Chichester, J. A.; Braun, A.; Yusibov, V. (2017). "Evaluation of inflammatory and immune responses in long-term cultured human precision-cut lung slices". Human Vaccines & Immunotherapeutics. 13 (2): 351–358. doi:10.1080/21645515.2017.1264794. PMC   5328235 . PMID   27929748.
  40. ↑ Davidovich, N.; Huang, J.; Margulies, S. S. (2013). "Reproducible uniform equibiaxial stretch of precision-cut lung slices". American Journal of Physiology. Lung Cellular and Molecular Physiology. 304 (4): L210-20. doi:10.1152/ajplung.00224.2012. PMC   3567360 . PMID   23275624.
  41. ↑ Dudek, M.; Puttur, F.; Arnold-Schrauf, C.; Kühl, A. A.; Holzmann, B.; Henriques-Normark, B.; Berod, L.; Sparwasser, T. (2016). "Lung epithelium and myeloid cells cooperate to clear acute pneumococcal infection". Mucosal Immunology. 9 (5): 1288–1502. doi:10.1038/mi.2015.128. PMC   4990776 . PMID   26627460.
  42. ↑ Martin, C.; Uhlig, S.; Ullrich, V. (1996). "Videomicroscopy of methacholine-induced contraction of individual airways in precision-cut lung slices". The European Respiratory Journal. 9 (12): 2479–2487. doi: 10.1183/09031936.96.09122479 . PMID   8980957.
  43. ↑ Craig, A.; Mai, J.; Cai, S.; Jeyaseelan, S. (2009). "Neutrophil recruitment to the lungs during bacterial pneumonia". Infection and Immunity. 77 (2): 568–575. doi:10.1128/IAI.00832-08. PMC   2632043 . PMID   19015252.
  44. ↑ Alsafadi, Hani N.; Staab-Weijnitz, Claudia A.; Lehmann, Mareike; Lindner, Michael; Peschel, Britta; Königshoff, Melanie; Wagner, Darcy E. (2017). "An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices". American Journal of Physiology. Lung Cellular and Molecular Physiology. 312 (6): L896–L902. doi: 10.1152/ajplung.00084.2017 . PMID   28314802. S2CID   2255748.
  45. ↑ Bates JHT; Smith, B. J. (2018). "Ventilator-induced lung injury and lung mechanics". Annals of Translational Medicine. 6 (19): 378. doi: 10.21037/atm.2018.06.29 . PMC   6212358 . PMID   30460252.
  46. ↑ Dassow, C.; Wiechert, L.; Martin, C.; Schumann, S.; Müller-Newen, G.; Pack, O.; Guttmann, J.; Wall, W. A.; Uhlig, S. (2010). "Biaxial distension of precision-cut lung slices". Journal of Applied Physiology. 108 (3): 713–721. doi:10.1152/japplphysiol.00229.2009. PMID   20075265.
  47. ↑ Dassow, C.; Wiechert, L.; Martin, C.; Schumann, S.; Müller-Newen, G.; Pack, O.; Guttmann, J.; Wall, W. A.; Uhlig, S. (2010). "Biaxial distension of precision-cut lung slices". Journal of Applied Physiology. 108 (3): 713–721. doi:10.1152/japplphysiol.00229.2009. PMID   20075265.
  48. 1 2 Ewart, L.; Dehne, E. M.; Fabre, K.; Gibbs, S.; Hickman, J.; Hornberg, E.; Ingelman-Sundberg, M.; Jang, K. J.; Jones, D. R.; Lauschke, V. M.; Marx, U.; Mettetal, J. T.; Pointon, A.; Williams, D.; Zimmermann, W. H.; Newham, P. (2018). "Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery". Annual Review of Pharmacology and Toxicology. 58: 65–82. doi:10.1146/annurev-pharmtox-010617-052722. PMID   29029591.
  49. ↑ complex.https://erj.ersjournals.com/content/9/12/2479.short
  50. ↑ Stucki, J. D.; Hobi, N.; Galimov, A.; Stucki, A. O.; Schneider-Daum, N.; Lehr, C. M.; Huwer, H.; Frick, M.; Funke-Chambour, M.; Geiser, T.; Guenat, O. T. (2018). "Medium throughput breathing human primary cell alveolus-on-chip model". Scientific Reports. 8 (1): 14359. Bibcode:2018NatSR...814359S. doi:10.1038/s41598-018-32523-x. PMC   6156575 . PMID   30254327.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.